Suppr超能文献

慢性丙型肝炎病毒感染不同疾病阶段准种的多样性及其在干扰素治疗中的意义。

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment.

作者信息

Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C

机构信息

Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Hepatology. 1995 Jul;22(1):30-5.

PMID:7541387
Abstract

Hepatitis C virus (HCV) populations in vivo exist as a mixture of heterogeneous viruses called quasispecies, which have variations in the hypervariable region (HRV). However, the relationship between the diversity of HVR quasispecies, the disease stage, or the interferon (IFN) responsiveness remains to be elucidated. To study these, serum samples were obtained from 42 patients with chronic hepatitis C virus infection; 24 with chronic active hepatitis (CAH) treated with IFN, 9 with cirrhosis, 9 with hepatocellular carcinoma (HCC). HCV quasispecies populations were separated by the single-strand conformation polymorphism (SSCP) method targeted to the HVR. The patients were classified into two groups; a single-band group (n = 12) in which HVR quasispecies was homogeneous and a multiple-band group (n = 30) in which HVR quasispecies was heterogeneous. Patients with multiple bands had significantly more advanced liver disease than those with a single-band group (P = .0082). The percentage of patients with single band were 41% in CAH, 22% in cirrhosis, and 0% in HCC. Multivariate analyses showed that viral diversity was independently related to the progression of liver disease and was not correlated with the duration of infection. We also found that in CAH, the patients who had multiple bands (n = 14) were more resistant to IFN therapy than those who had a single band (n = 10) (P = .002). These results indicate that the diversity of HCV quasispecies becomes more complex as the disease stage progresses and that CAH with more complex diversity shows less IFN effectiveness.

摘要

丙型肝炎病毒(HCV)在体内以称为准种的异质病毒混合物形式存在,这些病毒在高变区(HRV)存在变异。然而,HRV准种的多样性与疾病阶段或干扰素(IFN)反应性之间的关系仍有待阐明。为了研究这些关系,从42例慢性丙型肝炎病毒感染患者中获取血清样本;其中24例为接受IFN治疗的慢性活动性肝炎(CAH)患者,9例为肝硬化患者,9例为肝细胞癌(HCC)患者。通过针对HVR的单链构象多态性(SSCP)方法分离HCV准种群体。将患者分为两组;一组为单带组(n = 12),其中HVR准种是同质的,另一组为多带组(n = 30),其中HVR准种是异质的。多带组患者的肝病进展明显比单带组患者更严重(P = .0082)。单带患者在CAH中的比例为41%,在肝硬化中为22%,在HCC中为0%。多变量分析表明,病毒多样性与肝病进展独立相关,与感染持续时间无关。我们还发现,在CAH中,多带患者(n = 14)比单带患者(n = 10)对IFN治疗更具抗性(P = .002)。这些结果表明,随着疾病阶段的进展,HCV准种的多样性变得更加复杂,并且具有更复杂多样性的CAH显示出较低的IFN有效性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验